David Matthew Stark - 04 Mar 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Signature
/s/ Dov Bergwerk as attorney-in-fact for David M. Stark
Issuer symbol
TEVA
Transactions as of
04 Mar 2022
Net transactions value
-$240,718
Form type
4
Filing time
08 Mar 2022, 15:13:37 UTC
Previous filing
02 Mar 2022
Next filing
29 Jul 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +37,939 +177% 59,319 04 Mar 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale $127,262 -17,008 -29% $7.48 42,311 04 Mar 2022 Direct F1, F3, F4, F5
transaction TEVA Ordinary Shares Options Exercise +13,930 +33% 56,241 04 Mar 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale $46,736 -6,246 -11% $7.48 49,995 04 Mar 2022 Direct F1, F3, F4, F5
transaction TEVA Ordinary Shares Options Exercise +20,199 +40% 70,194 05 Mar 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale $66,720 -9,057 -13% $7.37 61,137 07 Mar 2022 Direct F1, F3, F4, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -37,939 -100% $0.000000* 0 04 Mar 2022 Ordinary Shares 37,939 Direct F1, F2, F7
transaction TEVA Restricted Share Units Options Exercise $0 -13,930 -50% $0.000000 13,931 04 Mar 2022 Ordinary Shares 13,930 Direct F1, F2, F8
transaction TEVA Restricted Share Units Award $0 +127,345 $0.000000 127,345 04 Mar 2022 Ordinary Shares 127,345 Direct F1, F2, F9
transaction TEVA Restricted Share Units Options Exercise $0 -20,199 -25% $0.000000 60,599 05 Mar 2022 Ordinary Shares 20,199 Direct F1, F2, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F4 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.49, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7 Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022.
F8 Restricted share units were granted on March 4, 2019, with 13,930 having vested on each of March 4, 2021 and March 4, 2022, and 13,931 vesting on March 4, 2023.
F9 Restricted share units were granted on March 4, 2022, with 31,836 vesting on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 31,837 vesting on March 4, 2026.
F10 Restricted share units were granted on March 5, 2021, with 20,199 having vested on March 5, 2022, 20,199 vesting on each of March 5, 2023 and March 5, 2024, and 20,201 vesting on March 5, 2025.